808 related articles for article (PubMed ID: 19661359)
41. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.
Hsu PK; Li AF; Wang YC; Hsieh CC; Huang MH; Hsu WH; Hsu HS
J Thorac Cardiovasc Surg; 2008 May; 135(5):1029-35. PubMed ID: 18455580
[TBL] [Abstract][Full Text] [Related]
42. Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma.
Wang Q; He W; Lu C; Wang Z; Wang J; Giercksky KE; Nesland JM; Suo Z
Anticancer Res; 2009 Apr; 29(4):1233-41. PubMed ID: 19414369
[TBL] [Abstract][Full Text] [Related]
43. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma.
Kobayashi H; Ishii Y; Takayama T
J Surg Oncol; 2005 Jun; 90(4):233-8. PubMed ID: 15906366
[TBL] [Abstract][Full Text] [Related]
44. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
45. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
Wakatsuki M; Suzuki Y; Nakamoto S; Ohno T; Ishikawa H; Kiyohara H; Kiyozuka M; Shirai K; Nakayama Y; Nakano T
J Gastroenterol Hepatol; 2007 May; 22(5):715-9. PubMed ID: 17444861
[TBL] [Abstract][Full Text] [Related]
46. Metastasizing vulvar carcinosarcoma with squamous carcinomatous and leiomyosarcomatous differentiation: genetic evidence of clonal origin.
Adam P; Zettl A; Zollner U; Dietl J; Müller-Hermelink HK; Eck M
Hum Pathol; 2005 Oct; 36(10):1143-7. PubMed ID: 16226117
[TBL] [Abstract][Full Text] [Related]
47. Spontaneous apoptosis in advanced esophageal carcinoma: its relation to Fas expression.
Shibakita M; Tachibana M; Dhar DK; Ohno S; Kubota H; Yoshimura H; Kinugasa S; Masunaga R; Nagasue N
Clin Cancer Res; 2000 Dec; 6(12):4755-9. PubMed ID: 11156230
[TBL] [Abstract][Full Text] [Related]
48. Primary carcinosarcoma of the liver: clinicopathologic features of 5 cases and a review of the literature.
Lao XM; Chen DY; Zhang YQ; Xiang J; Guo RP; Lin XJ; Li JQ
Am J Surg Pathol; 2007 Jun; 31(6):817-26. PubMed ID: 17527068
[TBL] [Abstract][Full Text] [Related]
49. Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray study.
Dong P; Li X; Yu Z; Lu G
J Laryngol Otol; 2007 Dec; 121(12):1177-83. PubMed ID: 17888194
[TBL] [Abstract][Full Text] [Related]
50. The expression of type IV collagen alpha6 chain is related to the prognosis in patients with esophageal squamous cell carcinoma.
Baba Y; Iyama K; Ikeda K; Ishikawa S; Hayashi N; Miyanari N; Sado Y; Ninomiya Y; Baba H
Ann Surg Oncol; 2008 Feb; 15(2):555-65. PubMed ID: 17955302
[TBL] [Abstract][Full Text] [Related]
51. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma.
Takatori H; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Sasaki K; Tamotsu K; Owaki T; Ishigami S; Aikou T
Eur J Surg Oncol; 2008 Apr; 34(4):397-402. PubMed ID: 17553653
[TBL] [Abstract][Full Text] [Related]
52. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
53. mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?
Boone J; Ten Kate FJ; Offerhaus GJ; van Diest PJ; Rinkes IH; van Hillegersberg R
J Clin Pathol; 2008 Aug; 61(8):909-13. PubMed ID: 18474542
[TBL] [Abstract][Full Text] [Related]
54. Positive impact on surgical treatment for asymptomatic patients with esophageal carcinoma.
Natsugoe S; Baba M; Shimada M; Kijima F; Kusano C; Yoshinaka H; Mueller J; Aikou T
Hepatogastroenterology; 1999; 46(29):2854-8. PubMed ID: 10576360
[TBL] [Abstract][Full Text] [Related]
55. Esophageal Carcinosarcoma with Basaloid Squamous Cell Carcinoma: A Case Report and Review of the Literature.
Ishida H; Fujishima F; Onodera Y; Konno-Kumagai T; Maruyama S; Okamoto H; Sato C; Heishi T; Sakurai T; Taniyama Y; Kamei T; Sasano H
Tohoku J Exp Med; 2019 Dec; 249(4):255-263. PubMed ID: 31852851
[TBL] [Abstract][Full Text] [Related]
56. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus.
Yamada A; Sasaki H; Aoyagi K; Sano M; Fujii S; Daiko H; Nishimura M; Yoshida T; Chiba T; Ochiai A
Oncol Rep; 2008 Nov; 20(5):1021-7. PubMed ID: 18949396
[TBL] [Abstract][Full Text] [Related]
57. Clinical relevance of Fas expression in oesophageal squamous cell carcinoma.
Chan KW; Lee PY; Lam AK; Law S; Wong J; Srivastava G
J Clin Pathol; 2006 Jan; 59(1):101-4. PubMed ID: 16394289
[TBL] [Abstract][Full Text] [Related]
58. An immunohistochemical study of helix pomatia agglutinin binding on carcinomas of the esophagus.
Yoshida Y; Okamura T; Shirakusa T
Surg Gynecol Obstet; 1993 Sep; 177(3):299-302. PubMed ID: 7689253
[TBL] [Abstract][Full Text] [Related]
59. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.
Makino T; Yamasaki M; Takemasa I; Takeno A; Nakamura Y; Miyata H; Takiguchi S; Fujiwara Y; Matsuura N; Mori M; Doki Y
Ann Surg Oncol; 2009 Jul; 16(7):2058-64. PubMed ID: 19408050
[TBL] [Abstract][Full Text] [Related]
60. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
Liu P; Chen W; Zhu H; Liu B; Song S; Shen W; Wang F; Tucker S; Zhong B; Wang D
Jpn J Clin Oncol; 2009 Oct; 39(10):644-50. PubMed ID: 19648590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
